39. Llamazares M, Cal S, Quesada V, Lo´pez-Ot´ın C (2003) Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloprotei- nases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain. J Biol Chem 278: 13382–9. 40. Somerville RP, Longpre JM, Jungers KA, Engle JM, Ross M, et al. (2003) Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 278: 9503–13. 41. Somerville RP, Jungers KA, Apte SS (2004) Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activation. J Biol Chem 279: 51208–17. 42. Bai XH, Wang DW, Luan Y, Yu XP, Liu CJ (2009) Regulation of chondrocyte differentiation by ADAMTS-12 metalloproteinase depends on its enzymatic activity. Cell Mol Life Sci 66: 667–80. 43. Masui T, Hosotani R, Tsuji S, Miyamoto Y, Yasuda S, et al. (2001) Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 7: 3437–43. 44. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537–49. 45. Rocks N, Paulissen G, Quesada Calvo F, Polette M, Gueders M, et al. (2006) Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer 94: 724–30. 46. Kuno K, Bannai K, Hakozaki M, Matsushima K, Hirose K (2004) The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. Biochem Biophys Res Commun 319: 1327–33. 47. Liu YJ, Xu Y, Tu Q (2006) Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene 25: 2452–67. 48. Llamazares M, Obaya AJ, Moncada-Pazos A, Heljasvaara R, Espada J, et al. (2007) The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J Cell Sci 120: 3544–52. 49. El Hour M, Moncada-Pazos A, Blacher S, Masset A, Cal S, et al. (2010) Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene 29: 3025–32. 50. Moncada-Pazos A, Obaya AJ, Fraga MF, Viloria CG, Capella´ G, et al. (2009) The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells ADAMTS-12 and Trophoblast Invasion and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 122: 2906–13. 51. Eyre D (2004) Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res 427: Suppl, S118–22. 52. Kuphal S, Bosserhoff A (2006) Influence of the cytoplasmic domain of E- cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene 25: 248–59. 53. Lamarca H, Ott C, Honer Z, Bentrup K, Pierson D, et al. (2005) Three- dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion. Placenta 26: 709–20. 54. Barczyk M, Carracedo S, Gulberg D (2010) Integrins. Cell Tissue Res 339: 269–80. 55. Felding-Habermann B, Cheresh D (1993) Vitronectin and its receptors. Curr Opin Cell Biol 5: 864–8. 56. Xu P, Wang Y, Pia Y, Bai S, Xia Z, et al. (2001) Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol Reprod 65: 240–6. 57. Brooks P, Clark R, Cheresh D (1994a) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569–71. 58. Jones J, Prevette T, Gockerman A, Clemmons D (1996) Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci U S A 93: 2482–7. 59. Gasparini G, Brooks P, Biganzoli E, Vermeulen P, Bonoldi E, et al. (1998) Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 4: 2625–34. 60. Camenisch G, Pisabarro M, Sherman D, Kowalski J, Nagel M, et al. (2002) ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 277: 17281–90. 61. Byzova T, Kim W, Midura R, Plow E (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254: 299–308. 62. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516–23. 63. Hamel MG, Ajmo JM, Leonardo CC, Zuo F, Sandy JD, et al. (2007) Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension. Exp Neurol 210: 428–40. PLoS ONE | www.plosone.org 15 April 2011 | Volume 6 | Issue 4 | e18473